4,5-Dimethoxycanthin-6-one Inhibits Glioblastoma Stem Cell and Tumor Growth by Inhibiting TSPAN1 Interaction with TM4SF1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

4,5-Dimethoxycanthin-6-one Inhibits Glioblastoma Stem Cell and Tumor Growth by Inhibiting TSPAN1 Interaction with TM4SF1

Published:2024-07-26 Issue:10 Volume:49 Page:2897-2909
ISSN:0364-3190
Container-title:Neurochemical Research
language:en
Short-container-title:Neurochem Res

Author:

Li Wei,Yang Li-jian,Xiong Yuan-yuan,Li Zeng-shi,Li Xi,Wen Yi

Funder

National Natural Science Foundation of China

Changsha Natural Science Foundation

Natural Science Foundation of Hunan Province

Scientific research plan of Hunan Provincial Health Commission

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11064-024-04211-y.pdf

Reference46 articles.

1. Lapointe S, Perry A, Butowski NA (2018) Primary brain tumours in adults. Lancet 392:432–446. https://doi.org/10.1016/s0140-6736(18)30990-5

2. Schaff LR, Mellinghoff IK (2023) Glioblastoma and other primary brain malignancies in adults: a review. JAMA 329:574–587. https://doi.org/10.1001/jama.2023.0023

3. Hotchkiss KM, Sampson JH (2021) Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor. J Neurooncol 151:55–62. https://doi.org/10.1007/s11060-020-03598-2

4. Morelli M, Lessi F, Barachini S, Liotti R, Montemurro N, Perrini P et al (2022) Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response early. Front Oncol 12:969812. https://doi.org/10.3389/fonc.2022.969812

5. Vigneswaran K, Boyd NH, Oh SY, Lallani S, Boucher A, Neill SG et al (2021) YAP/TAZ transcriptional coactivators create therapeutic vulnerability to Verteporfin in EGFR-mutant Glioblastoma. Clin Cancer Res 27:1553–1569. https://doi.org/10.1158/1078-0432.Ccr-20-0018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3